The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
112726042 11272604 2 F 20150616 20160823 20150715 20160902 EXP US-ROCHE-1607777 ROCHE 72.00 YR F Y 74.00000 KG 20160902 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
112726042 11272604 1 PS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) CYCEL=21?LAST DOSE PRIOR TO SAE ON 26/MAY/2015 (CYCLE 5, DAY1) 125085 15 MG/KG INFUSION
112726042 11272604 2 SS IPILIMUMAB IPILIMUMAB 1 Intravenous (not otherwise specified) LAST DOSE PRIOR TO SAE ON 05/MAY/2015 (CYCLE 4, DAY1) 0 3 MG/KG
112726042 11272604 3 C ASPIR 81 2 0
112726042 11272604 4 C CARVEDILOL. CARVEDILOL 1 0
112726042 11272604 5 C HEMP OIL CANNABIS SATIVA SEED OIL 1 0
112726042 11272604 6 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 0
112726042 11272604 7 C LIPITOR ATORVASTATIN CALCIUM 1 0
112726042 11272604 8 C LISINOPRIL. LISINOPRIL 1 0
112726042 11272604 9 C MELATONIN MELATONIN 1 0
112726042 11272604 10 C MILK THISTLE MILK THISTLE 1 0
112726042 11272604 11 C VITAMIN C ASCORBIC ACID 1 0
112726042 11272604 12 C VITAMIN B12 CYANOCOBALAMIN 1 0
112726042 11272604 13 C NORVASC AMLODIPINE BESYLATE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
112726042 11272604 1 Malignant melanoma
112726042 11272604 2 Malignant melanoma

Outcome of event

Event ID CASEID OUTC COD
112726042 11272604 OT
112726042 11272604 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
112726042 11272604 Hypertension
112726042 11272604 Sudden death

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
112726042 11272604 1 20150303 0
112726042 11272604 2 20150303 0